Deal Snapshot
Curaleaf to Acquire Majority Stake in Germany´s Four 20 Pharma
Friday 12 August 2022

US-based cannabis company Curaleaf Holdings, Inc's (CSE: CURA) (OTCQX: CURLF) Curaleaf International Holdings Ltd European holding company has signed a definitive agreement to acquire a 55% stake in German cannabis producer Four 20 Pharma GmbH, the company said.

Four 20 Pharma is a fully EU-GMP and GDP licensed German producer and distributor of medical cannabis with its own product line.

Date Published: 12/08/2022